CTLA-4 (CD152) is predominantly expressed on the surface of activated T cells as well as in regulatory T cells (Tregs) and PD-1+ CD4+/CD8+ tumor-infiltrating lymphocytes (TILs). This evidence concerns the gene CD8A and neoplasm.